Physician profile
Brian D Quinn
NPI 1578958567
$1,938.06
in general payments reported to CMS, 2019-2025
8 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $62.59 · 2023: $413 · 2024: $750 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $570.38 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $318.54 | 2022-2023 | Alphavac, Angiodynamics |
| Penumbra, INC. | $288.50 | 2021-2025 | Ruby Coil |
| Boston Scientific Corporation | $249.15 | 2022-2024 | Embold Fibered, Eluvia |
| Sirtex Medical INC | $140.51 | 2025 | Sir-Spheres Microspheres |
| Medtronic, INC. | $108.12 | 2021-2023 | Concertotm |
| Bard Peripheral Vascular, INC. | $47.14 | 2021-2022 | |
| Becton, Dickinson and Company | $44.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.